Reduction in postprandial glucose excursion and prolongation of satiety: Possible explanation of the long-term effects of whole grain Salba (Salvia Hispanica L.)

European Journal of Clinical Nutrition

Volumn 64, Issue 4, 2010, Pages 436-438

  Vuksan, V ^a,b,c   Jenkins, A L ^a   Dias, A G ^a,c   Lee, A S ^a,c   Jovanovski, E ^a   Rogovik, A L ^a   Hanna, A ^a,c  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Appetite; Glycemia; Salba; Whole grain

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE; SALBA; SALVIA HISPANICA OIL; UNCLASSIFIED DRUG; VEGETABLE OIL; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT;

ADULT; APPETITE; AREA UNDER THE CURVE; ARTICLE; BLOOD CLOTTING; BLOOD PRESSURE; BLOOD SAMPLING; BREAD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETES MELLITUS; DIET RESTRICTION; DIET SUPPLEMENTATION; DISEASE MARKER; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DOUBLE BLIND PROCEDURE; DRUG DOSE ESCALATION; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HEART PROTECTION; HUMAN; HUMAN EXPERIMENT; LOW DRUG DOSE; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; RANDOMIZED CONTROLLED TRIAL; SALVIA; SALVIA HISPANICA; SATIETY; TREATMENT DURATION; TREATMENT OUTCOME; ADMINISTRATION AND DOSAGE; CARBOHYDRATE DIET; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; HYPERGLYCEMIA; METABOLISM; PLANT SEED; REFERENCE VALUE; RISK FACTOR;

ADULT; APPETITE; AREA UNDER CURVE; BLOOD GLUCOSE; BREAD; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIETARY CARBOHYDRATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPERGLYCEMIA; MALE; PLANT EXTRACTS; PLANT PREPARATIONS; POSTPRANDIAL PERIOD; REFERENCE VALUES; RISK FACTORS; SALVIA; SATIATION; SEEDS;

SALVIA HISPANICA;

EID: 77950627163     PISSN: 09543007     EISSN: 14765640     Source Type: Journal    
DOI: 10.1038/ejcn.2009.159     Document Type: Article

References (14)

1. Blundell JE, Rogers PJ (1991). Hunger, hedonics, and the control of satiation and satiety. In: Friedman MI, Tordoff MG, Kare MR (eds). Chemical Senses, Vol IV. Appetite and Nutrition. Marcel Dekker: New York. pp 127-148.
2. Brouns F, Bjorck I, Frayn KN, Gibbs AL, Lang V, Slama G et al. (2005). Glycaemic index methodology. Nutr Res Rev 18, 145-171.
3. Ceriello A, Taboga C, Tonutti L, Giacomello R, Stel L, Motz E et al. (1996). Post-meal coagulation activation in diabetes mellitus: the effect of acarbose. Diabetologia 39, 469-473.
4. Chiasson JL (2006). Acarbose for the prevention of diabetes, hypertension, and cardiovascular disease in subjects with impaired glucose tolerance: the Study to Prevent Non-Insulin- Dependent Diabetes Mellitus (STOP-NIDDM) Trial. Endocr Pract 12 (Suppl 1), 25-30.
5. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M (2003). Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 290, 486-494.
6. Coutinho M, Gerstein HC, Wang Y, Yusuf S (1999). The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95 783 individuals followed for 12.4 years. Diabetes Care 22, 233-240.
7. Gentilcore D, Bryant B, Wishart JM, Morris HA, Horowitz M, Jones KL (2005). Acarbose attenuates the hypotensive response to sucrose and slows gastric emptying in the elderly. Am J Med 118, 1289.
8. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP et al. (2006). Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA 295, 1681-1687.
9. O'Keefe JH, Bell DS (2007). Postprandial hyperglycemia/hyperlipidemia (postprandial dysmetabolism) is a cardiovascular risk factor. Am J Cardiol 100, 899-904.
10. O'Keefe JH, Gheewala NM, O'Keefe JO (2008). Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J Am Coll Cardiol 51, 249-255.
11. Read N, French S, Cunningham K (1994). The role of the gut in regulating food intake in man. Nutr Rev 52, 1-10.
12. Shimabukuro M, Higa N, Chinen I, Yamakawa K, Takasu N (2006). Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study. J Clin Endocrinol Metab 91, 837-842.
13. Vuksan V, Whitham D, Sievenpiper JL, Jenkins AL, Rogovik AL, Bazinet RP et al. (2007). Supplementation of conventional therapy with the novel grain Salba (Salvia hispanica L.) improves major and emerging cardiovascular risk factors in type 2 diabetes: results of a randomized controlled trial. Diabetes Care 30, 2804-2810.
14. Wolever TM, Jenkins DJ, Jenkins AL, Josse RG (1991). The glycemic index: methodology and clinical implications. Am J Clin Nutr 54, 846-854.